Preemptive (neoadjuvant) chemotherapy: can analysis of eligibility criteria, prognostic factors, and tumor staging from different trials provide valid or useful comparisons?
作者信息
Raghavan D, Wallace M
机构信息
Urological Cancer Research Unit, Royal Prince Alfred Hospital, Sydney, Australia.